Steve Cohen‘s SAC Capital has just revealed a 5.3% stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a new filing with the SEC indicates. The filing, which is a 13G, indicates that Cohen is here for investment purposes only, and does not seek any activist changes.
Recommended Reading:
Karpus Management Ups Stakes in Zweig Total Return Fund and Western Asset Inflation Management Fund
